Clinical Trials Directory

Trials / Completed

CompletedNCT00250237

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

Randomised Double-blind Placebo-controlled Study of Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
220 (actual)
Sponsor
Bronovo Hospital · Academic / Other
Sex
All
Age
75 Years
Healthy volunteers
Accepted

Summary

In this study the investigators want to determine if treatment with haloperidol direct post-operatively after acute hip surgery in high risk patients protects against developing a post-operative delirium.

Detailed description

A post-operative delirium is a serious and frequent (35-65%) complication with high morbidity and mortality in high risk patients. In this study we investigate whether we can prevent a delirium from occuring after surgery in patients with a hip fracture of 75 years of age and older. It's a randomised double-blind single centre placebo-controlled study of haloperidol versus placebo.

Conditions

Interventions

TypeNameDescription
DRUGHaloperidolHaloperidol 1mg twice daily during 72hours
DRUGplaceboPlacebo 1mg twice daily during 72hours

Timeline

Start date
2005-11-01
Primary completion
2008-11-01
Completion
2009-02-01
First posted
2005-11-08
Last updated
2009-08-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00250237. Inclusion in this directory is not an endorsement.

Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery (NCT00250237) · Clinical Trials Directory